Immunogenicity and Cross Protective Ability of the Central VP2 Amino Acids of Infectious Pancreatic Necrosis Virus in Atlantic Salmon (Salmo salar L.)

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Munang'andu, Hetron M ^a   Sandtrø, Ane ^a   Mutoloki, Stephen ^a   Brudeseth, Bjørn E ^b   Santi, Nina ^c   Evensen, Øystein ^a  

^a NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^b ZOETIS   (United States)

^c Aqua Gen AS   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; PROTEIN VP2; VIRUS VACCINE;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; ATLANTIC SALMON; CONTROLLED STUDY; CROSS PROTECTION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HOST PATHOGEN INTERACTION; IMMUNOGENICITY; INFECTIOUS PANCREATIC NECROSIS VIRUS; MORTALITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROGENY; PROTEIN LOCALIZATION; PROTEIN PURIFICATION; VACCINATION; VIRAL GENETICS; VIRUS CAPSID; VIRUS INACTIVATION; VIRUS INFECTION; VIRUS NEUTRALIZATION; VIRUS STRAIN;

ALANINE; AMINO ACIDS; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CROSS REACTIONS; FISH DISEASES; HOST-PATHOGEN INTERACTIONS; IMMUNOHISTOCHEMISTRY; INFECTIOUS PANCREATIC NECROSIS VIRUS; PANCREAS, EXOCRINE; PROLINE; SALMO SALAR; SURVIVAL ANALYSIS; SURVIVAL RATE; THREONINE; TIME FACTORS; VACCINATION; VACCINES, ATTENUATED; VACCINES, INACTIVATED; VIRAL STRUCTURAL PROTEINS; VIRAL VACCINES;

BIRNAVIRIDAE; INFECTIOUS PANCREATIC NECROSIS VIRUS; MIRIDAE; SALMO SALAR; SALMONIDAE;

EID: 84872664659     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054263     Document Type: Article

References (43)

1. Evensen O, Santi N (2008) Infectious pancreatic necrosis virus. In: Mahy BWJ and van Regenmortel MVH(eds), editors. In encyclopedia of virology, 3rd virology edn. Elsevier: Oxford. pp. 83-89.
2. Dobos P, Roberts TE, (1983) The molecular biology of infectious pancreatic necrosis virus - A review. Can J Microbiol 29: 377-384.
3. Dobos P, (1976) Size and structure of genome of infectious pancreatic necrosis virus. Nucleic Acids Res 3: 1903-1924.
4. Dobos P, Rowe D, (1977) Peptide map comparison of infectious pancreatic necrosis virus-specific polypeptides. J Virol 24: 805-820.
5. Heppell J, Tarrab E, Lecomte J, Berthiaume L, Arella M, (1995) Strain variability and localization of important epitopes on the major structuralprotein (VP2) of infectious pancreatic necrosis virus. Virology 214: 40-49.
6. Dominguez J, Hedrick RP, Sanchezvizcaino JM, (1990) Use of monoclonal antibodies for detection of infectious pancreatic necrosis virus by the enzyme-linked-immunosorbent-assay (ELISA). Dis Aquat Organ 8: 157-163.
7. Liao L, Dobos P, (1995) Mapping of a serotype-specific epitope of the major capsid protein VP2 of infectious pancreatic necrosis virus. Virology 209: 684-687.
8. Tarrab E, Berthiaume L, Heppell J, Arella M, Lecomte J, (1993) Antigenic characterization of serogroup-A of infectious pancreatic necrosis virus with 3 panels of monoclonal antibodies. J Gen Virol 74: 2025-2030.
9. Tarrab E, Berthiaume L, Grothe S, Oconnormccourt M, Heppell J, et al. (1995) Evidence of a major neutralizable conformational epitope region on VP2 of infectious pancreatic necrosis virus. J Gen Virol 76: 551-558.
10. Wolski SC, Roberson BS, Hetrick FM, (1986) Monoclonal antibodies to the SP strain of infectious pancreatic necrosis virus. Vet Immunol Immunopathol 12: 373-381.
11. Bootland LM, Dobos P, Stevenson RMW, (1991) The IPNV carrier state and demonstration of vertical transmission in experimentally infected brook trout. Dis Auat Org 10: 13-21.
12. Melby HP, Falk K, (1995) Study of the interaction between a persistent infectious pancreatic necrosis virus (IPNV) infection and experimental infectious salmon anaemia (ISA) in Atlantic salmon, Salmo salar L. J Fish Dis. 18: 579-586.
13. Bootland LM, Dobos P, Stevenson RMW, (1986) Experimental induction of the carrier state in yearling brook trout - A model challenge protocol for IPNV immunization. Vet Immunol Immunopathol 12: 365-372.
14. Melby HP, Christie KE, (1994) Antigenic analysis of reference strains and Norwegianfield strains of aquatic birnaviruses by the use of 6 monoclonal-antibodies produced against the infectious pancreatic necrosis virus N1 strain. J Fish Dis 17: 409-415.
15. Munang'andu HM, Fredriksen BN, Mutoloki S, Brudeseth B, Kuo TY, et al. (2012) Comparison of vaccine efficacy for different antigen delivery systems for infectious pancreatic necrosis virus vaccines in Atlantic salmon (Salmo salar L.) in a cohabitation challenge model. Vaccine 30: 4007-4016.
16. Biering E, Villoing S, Sommerset I, Christie KE, (2005) Update on viral vaccines in fish. Progress in fish vaccinology Eidted by Midtlyng P J in Developments in Biologicals 121: 97-113.
17. Gomez-Casado E, Estepa A, Coll JM, (2011) A comparative review on European-farmed finfish RNA viruses and their vaccines. Vaccine 29: 2657-2671.
18. Gudding R, Lillehaug A, Evensen O, (1999) Recent developments in fish vaccinology. Vet Immunol Immunopathol 72: 203-212.
19. Santi N, Vakharia VN, Evensen O, (2004) Identification of putative motifs involved in the virulence of infectious pancreatic necrosis virus. Virology 322: 31-40.
20. Bain N, Gregory A, Raynard RS, (2008) Genetic analysis of infectious pancreatic necrosis virus from Scotland. J Fish Dis 31: 37-47.
21. Bruslind LD, Reno PW, (2000) Virulence comparison of three buhl-subtype isolates of infectious pancreatic necrosis virus in brook trout fry. J Aquat Anim Health 12: 301-315.
22. Mutoloki S, Evensen O, (2011) Sequence similarities of the capsid gene of Chilean and European isolates of infectious pancreatic necrosis virus point towards a common origin. J Gen Virol 92: 1721-1726.
23. Skjesol A, Skjaeveland I, Elnaes M, Timmerhaus G, Fredriksen BN, et al. (2011) IPNV with high and low virulence: host immune responses and viral mutations during infection. Virol J 8: 396.
24. Hahn CS, Dalrymple JM, Strauss JH, Rice CM, (1987) Comparison of the virulent Asibi strain of Yellow fever virus with the 17D vaccine strain derived from It. Proc Natl Acad Sci U S A 84: 2019-2023.
25. Song HC, Santi N, Evensen O, Vakharia VN, (2005) Molecular determinants of infectious pancreatic necrosis virus virulence and cell culture adaptation. J Virol 79: 10289-10299.
26. Yao K, Vakharia VN, (1998) Generation of infectious pancreatic necrosis virus from cloned cDNA. J Virol 72: 8913-8920.
27. Santi N, Sandtro A, Sindre H, Song HC, Hong JR, et al. (2005) Infectious pancreatic necrosis virus induces apoptosis in vitro and in vivo independent of VP5 expression. Virology 342: 13-25.
28. Santi N, Song H, Vakharia VN, Evensen O, (2005) Infectious pancreatic necrosis virus VP5 is dispensable for virulence and persistence. J Virol 79: 9206-9216.
29. Caswell-Reno P, Lipipun V, Reno PW, Nicholson BL, (1989) Use of a group a reactive and other monoclonal atibodies in an enzyme immunodot assay for identification and presumptive serotyping of aquatic birnaviruses. J Clin Microbiol 27: 1924-1929.
30. Frost P, Havarstein LS, Lygren B, Stahl S, Endresen C, et al. (1995) Mapping of neutralization epitopes on infectious pancreatic necrosis viruses. J Gen Virol 76: 1165-1172.
31. Calhoun K, Lin A, Bryant-Greenwood P, Lum C, Johnson D, et al. (2011) Field histology point care microscopic technique. Archives of Pathology & Laboratory Medicine 135: 207-210.
32. Evensen O, Rimstad E, (1990) Immunohistochemical identification of infectious pancreatic necrosls virus in paraffin embedded tissue of Atlantic salmon (Salmo salar L). J Vet Diagn Invest 2: 288-293.
33. Kaplan EL, Meier P, (1958) Nonparametric estimation from incomplete observations. J Am Statist Assn 53: 457-481.
34. Broome CV, (1991) Vaccine efficacy determination. NIPH Ann 14: 219-221.
35. Munang'andu HM, Fredriksen BN, Mutoloki S, Brudeseth B, Kuo TY, et al. (2012) Comparison of vaccine efficacy for different antigen delivery systems for infectious pancreatic necrosis virus vaccines in Atlantic salmon (Salmo salar L.) in a cohabitation challenge model. Vaccine 30: 4007-4016. S0264-410X(12)00570-1 [pii];10.1016/j.vaccine.2012.04.039 [doi].
36. Levitz SM, Golenbock DT, (2012) Beyond empiricism: Informing vaccine development through innate immunity research. Cell 148: 1284-1292.
37. Audibert F, (2003) Adjuvants for vaccines, a quest. Int Immunopharmacol 3: 1187-1193.
38. Davies JR, Grilli EA, (1989) Natural or vaccine induced antibody as a predictor of immunity in the face of natural challenge with influenza viruses. Epidemiol Infect 102: 325-333.
39. Meiklejohn G, Kempe CH, Thalman WG, Lennette EH, (1952) Evaluation of monovalent influenza vaccines. 2. observations during an influenza a prime epidemic. Am J Hyg 55: 12-21.
40. Belshe RB, Gruber WC, Mendelman PM, Mehta HB, Mahmood K, et al. (2000) Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J Infect Dis 181: 1133-1137.
41. Goodeve A, Potter CW, Clark A, Jennings R, Schild GC, et al. (1983) A graded-dose study of inactivated, surface-antigen influenza-B vaccine in volunteers - reactogenicity, antibody-response and protection to challenge virus infection. J Hyg 90: 107-115.
42. Masurel N, Laufer J, (1984) A one-year study of trivalent influenza vaccines in primed and unprimed volunteers - immunogenicity, clinical reactions and protection. J Hyg 92: 263-276.
43. Coulibaly F, Chevalier C, Delmas B, Rey FA, (2010) Crystal structure of an aquabirnavirus particle: Insights into antigenic diversity and virulence determinism. J Virol 84: 1792-1799.